跳至主要内容
临床试验/RPCEC00000066
RPCEC00000066已完成2 期

Intralesional application of the CIGB-128 in the Basal cell carcinoma.

Center for Genetic Engineering and Biotechnology (CIGB)0 个研究点目标入组 60 人开始时间: 2010年12月28日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Active. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
18 years 至 one(—)
性别
All

入选标准

  • Age equal or superior to 18 years. Informed consent given by the patient. Patients with clinical and histological diagnosis of B.C.C. Lesions of any clinical variant, location and color of the skin. Size of the lesion from 1 to 4 cm. No recurrent or recurrent previously treated disease.

排除标准

  • Pregnant or lactating women. A history of hypersensitivity to interferon or any excipient in the study treatment. Acute or chronic hepatic disease (AST and ALT > 2 times upper limit of normal and/or serum total bilirubin >17 _mol/L). Acute or chronic renal disease. Uncompensated heart insufficiency.

研究者

发起方
Center for Genetic Engineering and Biotechnology (CIGB)

相似试验

尚未招募
1 期
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study)Recurrent and/or progressive diffuse brain tumors (benign or malign), at any stage, without other therapeutic options.
RPCEC00000140Center for Genetic Engineering and Biotechnology (CIGB)30
尚未招募
2 期
CERVICONC-II-300 studyCervical cancer in stages IB2 and II.Uterine Cervical NeoplasmsUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital Diseases
RPCEC00000285Center for Genetic Engineering and Biotechnology (CIGB), in Havana144
已完成
2 期
Application of CIGB-128 in keloid patients undergoing surgical exeresis.CicatrixKeloidsKeloid/surgeryGranulation TissueConnective TissueCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesFibrosisPathologic Processes
RPCEC00000061Center for Genetic Engineering and Biotechnology (CIGB)45
已完成
1 期
Phase I with CIGB-814 in rheumatoid arthritis patientsArthritis, RheumatoidArthritisJoint DiseasesRheumatic DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesRheumatoid Arthritis
RPCEC00000238Center for Genetic Engineering and Biotechnology (CIGB), in Havana18
招募中
不适用
VIDA studyCOVID-19 respiratory distressCOVID-19Respiration DisordersRespiratory Tract DiseasesCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusSevere Acute Respiratory Syndrome
RPCEC00000321Center for Genetic Engineering and Biotechnology (CIGB), in Havana